Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genpact's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genpact's regulatory disclosures and financial reporting.
Madden James C. reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director James C. Madden received an equity award of 9,999 restricted share units (RSUs) of common shares. The award was granted at no cash cost per unit and increases his directly held common share interest to 73,067 shares.
Each RSU represents the right to receive one common share in the future. Subject to his continued service, all RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
Genpact Ltd: 03/13/2026 amendment shows The Vanguard Group reports 0 shares beneficially owned and 0% of Common Stock. The filing explains an internal realignment effective 01/12/2026 that led certain Vanguard subsidiaries to report ownership separately.
The statement lists no voting or dispositive power for Vanguard over Genpact common shares and affirms no single other person holds more than 5% of the class according to the report.
Genpact LTD Chief Financial Officer Michael Hal Weiner reported a tax-related share disposition linked to equity compensation. On the vesting of performance share units granted on March 15, 2023, 7,019 common shares were withheld at $38.92 per share to cover tax obligations. Following this non-market transaction, he holds 181,874 common shares directly.
Genpact Limited Senior Vice President Riju Vashisht reported a tax-related share disposition. On this Form 4, 7,080 common shares were withheld at $38.92 per share to cover taxes due upon vesting of performance share units granted on March 15, 2023. After this withholding, Vashisht directly holds 123,668 Genpact common shares.
Genpact LTD Senior Vice President Anil Nanduru reported a routine tax-withholding transaction related to equity compensation. On this Form 4, 7,663 common shares were withheld at a price of $38.92 per share to cover taxes due upon the vesting of performance share units granted on March 15, 2023 under Genpact’s 2017 Omnibus Incentive Compensation Plan. After this non-market disposition, Nanduru directly holds 105,539 common shares, indicating the filing reflects compensation-related tax settlement rather than an open-market sale.
Genpact Limited reported a routine compensation-related share withholding for its Senior Vice President and CHRO, Piyush Mehta. On March 10, 5,702 common shares were withheld at $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023. Following this tax-withholding disposition, Mehta directly holds 156,485 common shares, reflecting his ongoing equity stake in the company rather than an open-market sale.
Genpact Limited Senior Vice President Sameer Dewan reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,542 common shares were withheld at a value of $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023.
After this withholding, Dewan directly holds 57,665 common shares. This transaction reflects routine tax withholding on vested performance-based awards under the Genpact Limited 2017 Omnibus Incentive Compensation Plan rather than an open-market purchase or sale decision.
Genpact Limited President and CEO Balkrishan Kalra reported a tax-related share withholding. On the vesting of performance share units granted on March 15, 2023, 13,893 common shares were withheld to cover tax obligations, rather than sold in the market. Following this non-market disposition, he continues to hold 511,114 common shares directly.
Genpact Limited is soliciting proxies for its 2026 Annual General Meeting on April 23, 2026 in New York. Shareholders are being asked to elect ten directors, approve executive pay on an advisory basis, and ratify KPMG as independent auditor for 2026.
For 2025, Genpact reported net revenues of $5.08 billion, up 6.6% year-over-year, with Advanced Technology Solutions reaching $1.20 billion, up 17.0% and now 24% of total revenue. Adjusted diluted EPS grew 11%, marking a fifth straight year of EPS growth outpacing revenue. The company highlights a strategy centered on AI- and agentic-based solutions, strong partner-driven revenue growth, and extensive governance practices including an independent chair, fully independent key committees, annual director elections, and robust shareholder engagement on compensation.